Microvolt T-wave alternans: an effective approach to risk stratification in ischemic cardiomyopathy?
暂无分享，去创建一个
[1] Brahmajee K Nallamothu,et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. , 2007, Journal of the American College of Cardiology.
[2] Akshay S. Desai,et al. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. , 2006, Journal of cardiac failure.
[3] P. Chan,et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[4] J Thomas Bigger,et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. , 2006, Journal of the American College of Cardiology.
[5] J. A. Gomes,et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. , 2005, Journal of the American College of Cardiology.
[6] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[7] J. Ruskin,et al. Electrical alternans and vulnerability to ventricular arrhythmias. , 1994, The New England journal of medicine.